Metropolitan Life Insurance Company (MetLife)’s Vaxart VXRT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-8,060
| Closed | -$7.75K | – | 2472 |
|
2022
Q4 | $7.75K | Buy |
8,060
+535
| +7% | +$514 | ﹤0.01% | 2333 |
|
2022
Q3 | $16.4K | Buy |
7,525
+2,306
| +44% | +$5.03K | ﹤0.01% | 2119 |
|
2022
Q2 | $18.3K | Sell |
5,219
-2,995
| -36% | -$10.5K | ﹤0.01% | 2085 |
|
2022
Q1 | $41.4K | Sell |
8,214
-17,604
| -68% | -$88.7K | ﹤0.01% | 1705 |
|
2021
Q4 | $162K | Sell |
25,818
-877
| -3% | -$5.5K | ﹤0.01% | 2165 |
|
2021
Q3 | $212K | Sell |
26,695
-7,558
| -22% | -$60.1K | ﹤0.01% | 2021 |
|
2021
Q2 | $257K | Buy |
34,253
+20,008
| +140% | +$150K | ﹤0.01% | 1973 |
|
2021
Q1 | $86.2K | Sell |
14,245
-2,486
| -15% | -$15K | ﹤0.01% | 2465 |
|
2020
Q4 | $95.5K | Buy |
16,731
+1,123
| +7% | +$6.41K | ﹤0.01% | 2378 |
|
2020
Q3 | $104K | Buy |
15,608
+222
| +1% | +$1.48K | ﹤0.01% | 2197 |
|
2020
Q2 | $136K | Buy |
+15,386
| New | +$136K | ﹤0.01% | 2066 |
|